Snowden Capital Advisors LLC Crispr Therapeutics Ag Transaction History

Snowden Capital Advisors LLC

$3.29 Billion
Q3 2024

A detailed history of Snowden Capital Advisors LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 9,818 shares of CRSP stock, worth $379,465. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,818

Previous 9,782 0.37%

Holding current value

$379,465

Previous $528,000 12.69%

% of portfolio

0.01%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$44.62 - $62.75 $1,606 - $2,259	36 Added 0.37%	9,818 $461,000
Q2 2024 Aug 14, 2024	BUY	$51.17 - $68.18 $12,127 - $16,158	237 Added 2.48%	9,782 $528,000
Q1 2024 May 15, 2024	BUY	$60.67 - $89.12 $207,006 - $304,077	3,412 Added 55.63%	9,545 $650,000
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $25,798 - $48,216	668 Added 12.22%	6,133 $383,000
Q3 2023 Nov 14, 2023	SELL	$45.39 - $59.0 $15,750 - $20,473	-347 Reduced 5.97%	5,465 $248,000
Q1 2023 May 15, 2023	SELL	$41.0 - $56.12 $31,898 - $43,661	-778 Reduced 11.81%	5,812 $262,000
Q4 2022 Feb 13, 2023	SELL	$39.19 - $65.67 $979 - $1,641	-25 Reduced 0.38%	6,590 $267,000
Q3 2022 Nov 09, 2022	SELL	$61.1 - $83.78 $60,672 - $83,193	-993 Reduced 13.05%	6,615 $432,000
Q2 2022 Aug 12, 2022	SELL	$43.23 - $73.83 $36,918 - $63,050	-854 Reduced 10.09%	7,608 $462,000
Q1 2022 May 16, 2022	SELL	$53.19 - $79.24 $55,477 - $82,647	-1,043 Reduced 10.97%	8,462 $531,000
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $666,205 - $1.06 Million	9,505 New	9,505 $720,000
Q3 2021 Feb 05, 2024	BUY	$110.2 - $156.64 $905,733 - $1.29 Million	8,219 Added 150.39%	13,684 $1.53 Billion
Q2 2021 Jan 08, 2024	SELL	$100.84 - $161.89 $551,393 - $885,214	-5,468 Reduced 29.22%	13,247 $2.14 Billion
Q1 2021 Jan 08, 2024	BUY	$110.72 - $210.04 $257,202 - $487,922	2,323 Added 14.17%	18,715 $2.28 Billion
Q4 2020 Jan 08, 2024	BUY	$79.67 - $173.23 $1.31 Million - $2.84 Million	16,392 New	16,392 $2.51 Billion
Q3 2019 Jan 08, 2024	SELL	$40.99 - $52.56 $819,800 - $1.05 Million	-20,000 Closed	0 $0
Q2 2019 Jan 08, 2024	BUY	$35.45 - $48.2 $515,265 - $700,587	14,535 Added 265.97%	20,000 $1.18 Million

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.02B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Account

Snowden Capital Advisors LLC Crispr Therapeutics Ag Transaction History